Search Results
Found 1 results
510(k) Data Aggregation
(71 days)
The Atrium Flixene Graft is intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access. Insufficient data is available at this time to support Atrium Flixene Graft use in aortocoronary bypass applications or for use as a patch.
Not Found
The provided text is a 510(k) clearance letter from the FDA for a vascular graft device. It states the review of the premarket notification and the determination of substantial equivalence to legally marketed predicate devices.
However, the document does not contain any information about acceptance criteria or the study that proves the device meets such criteria. It is a regulatory clearance document, not a scientific study report or a summary of performance data.
Therefore, I cannot provide the requested information. The sections you asked for, such as sample size, data provenance, expert qualifications, adjudication methods, MRMC studies, standalone performance, ground truth details, and training set information, are not present in this regulatory letter.
Ask a specific question about this device
Page 1 of 1